Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-16 | 2024-06 | -9.91 | -19.28 | -9.37 | -94.55% |
2024-05-13 | 2024-03 | -16.61 | -5.75 | 10.86 | 65.38% |
2024-04-01 | 2023-12 | -49.84 | -27.48 | 22.36 | 44.86% |
2023-11-09 | 2023-09 | -47.6 | -58.47 | -10.87 | -22.84% |
2023-08-10 | 2023-06 | -88.82 | -85.62 | 3.2 | 3.60% |
2023-05-08 | 2023-03 | -79.87 | -103.83 | -23.96 | -30.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-31 | Alliance Global Partners | Upgrade | Buy | Buy |
2023-06-01 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-30 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-10 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-02-24 | Alliance Global Partners | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-08-12 | BAGGER RICHARD H | Director | 10.00K | Purchase |
2020-08-19 | BELL MARGARET SMITH | Director | 5.39K | Purchase |
2021-05-24 | GOODMAN DANIEL WINTNER M.D. | Director | 5.00K | Purchase |
2022-06-28 | LEDERMAN SETH | Chief Executive Officer | 0.00 | Purchase |
2018-06-24 | MARIO ERNEST B | Director | 0.00 | Purchase |
2018-06-13 | MORRIS JESSICA EDGAR | Chief Operating Officer | 1.64K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 398.75K | 630.03K | 2.24% |
2023-06-29 | Renaissance Technologies, LLC | 211.42K | 334.05K | 1.19% |
2023-06-29 | Geode Capital Management, LLC | 85.37K | 134.88K | 0.48% |
2023-06-29 | Acadian Asset Management. LLC | 68.74K | 108.61K | 0.39% |
2023-06-29 | Blackrock Inc. | 48.34K | 76.38K | 0.27% |
2023-06-29 | Raymond James & Associates, Inc. | 44.36K | 70.10K | 0.25% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 297.30K | 469.74K | 1.67% |
2023-06-29 | Vanguard Extended Market Index Fund | 100.84K | 159.33K | 0.57% |
2023-05-30 | Fidelity Extended Market Index Fund | 49.98K | 89.47K | 0.28% |
2023-05-30 | Fidelity Total Market Index Fund | 13.51K | 24.18K | 0.08% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.14K | 16.35K | 0.05% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 6.31K | 6.10K | 0.04% |
Split | Date |
---|---|
1 : 32 | 2024-06-10 |
4 : 25 | 2023-05-10 |
1 : 32 | 2022-05-17 |
1 : 10 | 2019-11-01 |
1 : 10 | 2018-11-28 |
1 : 10 | 2017-03-17 |
-
-
Hold or you’ll buy back when higher.
-
BIg TNXP conference is tomorrow, SNN Network Virtual Investor Conference
August 6, 2020 • 10:00 am ET -
Finally, my yes are in tears , can’t wait for tomorrow BIG TNXP conference
-
Over 2 eow
-
The BIG conference is tomorrow, SNN Network Virtual Investor Conference
August 6, 2020 • 10:00 am ET
Webcast -
Pose hour and rocket ah
-
Tomorrow the big conference
-
Lot of volume pouring in now
-
This stock is trying to explode, what is holding it back?
-
-
I think they increased the shears in July, there is no news about increasing the shears again, and most probably they will not dilute them until the end of this year
-
TNXP is buying 40,000 square foot facility where they can produce and deposit millions of vaccines, but why are they spending so much money if they didn’t discovered the vaccine for COVID-19? Keep in mind that they have a lot of contracts and partnership, after 6 August conference this stock will go UP UP UP,
-
$TNXP 20,000 @ $1.45 waiting for $10
-
$TNXP what a little gem! Are you ready! $10
-
If the company is doing so bad then why they buy 40,000 square foot facility where they can produce and deposit millions of vaccines? Keep in mind that they have a lot of contracts and partnership, after 6 August conference this stock will go UP UP UP,
-
-
The Tnxp conference will start in 2:15 h
-
If the company is doing so bad then why they buy 40,000 square foot facility where they can produce and deposit millions of vaccines? Keep in mind that they have a lot of contracts and partnership, after 6 August conference this stock will go UP UP UP,
-
https://sec.report/Document/0001387131-20-006373/
Nasdaq Global Market symbol
“TNXP”
The number of shares of Common Stock to be outstanding after this offering is based on 104,803,906 shares of Common Stock outstanding at July 10, 2020 and excludes the following:
●
10,021,786 shares of Common Stock issuable upon exercise of stock options outstanding at a weighted-average exercise price of $2.98 per share;●
5,184,210 shares of Common Stock issuable upon exercise of warrants outstanding at a weighted-average exercise price of $4.55 per share;●
643,750 shares of Common Stock reserved and available for issuance under our equity compensation plan; and●
300,000 shares of Common Stock reserved and available for issuance under our employee stock purchase plan.
-
Taking the lead: Tonix Pharmaceuticals Holding Corp (TNXP)
news.google.com • -
Examining Tonix Pharmaceuticals Holding Corp (TNXP) stock is warranted
news.google.com • -
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
globenewswire.com • -
Tonix Pharmaceuticals Announces Proposed Public Offering
globenewswire.com • -
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
globenewswire.com • -
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
investorplace.com •